NEW YORK (GenomeWeb News) – Mutations in an obesity-associated gene called FTO can contribute to melanoma risk through a pathway that appears independent of body mass index, according to a Nature Genetics article by members of an international melanoma consortium known as GenoMEL. With the help of imputed genotype information, the group conducted a multi-phase association study starting with nearly 1,400 European or Israeli individuals with melanoma and more than 3,500 unaffected controls from Europe.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A research duo estimates in PLOS One the number of papers that have used misidentified cell lines.

UK's National Institute for Health and Care Excellence approves GlaxoSmithKline's SCID gene therapy despite cost.

Science reports that Brazilian researchers are petitioning for the reversal of budget cuts.

In PLOS this week: gene flow patterns in common ash, guidelines for using morpholinos in zebrafish, and more.